Previous studies have indicated that sodium butyrate (NaB) inhibits the inflammation of lipopolysaccharide (LPS)-induced acute lung injury (ALI) by regulating the toll-like receptors 4 (TLR4)/nuclear factor kappa-B (NF-κB) signaling pathway (15). Here, TLR4 is linked to acute lung injury.